Showing results (1091-1100 of 1,193) with videos related to
Sort By:
Pageof 120
Journal of Pharmaceutical Sciences|April 1, 2011
PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 2: comparative assessment of prediction methods of human volume of distributionRhys Do Jones, Hannah M Jones, Malcolm Rowland, et al.Journal of Pharmaceutical Sciences|May 5, 2011
PHRMA CPCDC initiative on predictive models of human pharmacokinetics, part 5: prediction of plasma concentration-time profiles in human by using the physiologically-based pharmacokinetic modeling approachPatrick Poulin, Rhys D O Jones, Hannah M Jones, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 11, 2013
Functional maturation of the executive system during adolescenceTheodore D Satterthwaite, Daniel H Wolf, Guray Erus, et al.Biorxiv : the Preprint Server for Biology|March 31, 2025
Targeting CHEK2-YBX1&YBX3 regulatory hub to potentiate immune checkpoint blockade response in gliomasHeba Ali, Ningjia Zhou, Li Chen, et al.The Journal of Clinical Investigation|October 17, 2023
Metixene is an incomplete autophagy inducer in preclinical models of metastatic cancer and brain metastasesJawad Fares, Edgar Petrosyan, Deepak Kanojia, et al.Journal of Child Psychology and Psychiatry, and Allied Disciplines|April 7, 2021
Diagnostic shifts in autism spectrum disorder can be linked to the fuzzy nature of the diagnostic boundary: a data-driven approachBirkan Tunç, Juhi Pandey, Tanya St John, et al.Neuron|October 6, 2022
A brain atlas of synapse protein lifetime across the mouse lifespanEdita Bulovaite, Zhen Qiu, Maximilian Kratschke, et al.ACS Medicinal Chemistry Letters|November 19, 2021
BMS-813160: A Potent CCR2 and CCR5 Dual Antagonist Selected as a Clinical CandidateRobert J Cherney, Prakash Anjanappa, Kumaravel Selvakumar, et al.Future Oncology (London, England)|October 15, 2025
HERTHENA-PanTumor01: a phase II study of patritumab deruxtecan (HER3-DXd) in previously treated advanced solid tumorsThomas Powles, Aarti Bhatia, Barbara Burtness, et al.Melanoma Research|November 25, 2020
Safety and efficacy of combination nivolumab plus ipilimumab in patients with advanced melanoma: results from a North American expanded access program (CheckMate 218)F Stephen Hodi, Paul B Chapman, Mario Sznol, et al.Pageof 120